Author: Daniel snow

[ad_1] Amgen CEO Bob Bradway told CNBC’s Jim Cramer he thinks his company’s obesity drug can help patients manage weight loss long term, which he indicated is a challenge.”We think we can address one of the reasons that the field is struggling a little bit, which is the patient persistence issue,” Bradway said. Amgen revealed Monday that a trial of its experimental GLP-1 drug, MariTide, showed that patients were able to maintain weight loss for two years when given a monthly injection. Right now, most widely-used weight loss injections are taken weekly. Bradway told Cramer that the pharmaceutical giant expects…

[ad_1] U.S. dollar: Buy on the subpoena, sell on the indictment- StanChart [ad_2] Source link

[ad_1] USD/JPY: BofA sees yen weakness ahead of potential snap election [ad_2] Source link

[ad_1] China’s central bank likely to reverse FX measures as yuan strengthens [ad_2] Source link

[ad_1] EUR/PLN and USD/PLN price forecast for 2026, as per UBS [ad_2] Source link

[ad_1] Dollar edges higher ahead of CPI; yen drops sharply [ad_2] Source link

[ad_1] BofA sees AUD strength continuing as EUR/AUD downtrend has room to fall [ad_2] Source link

[ad_1] Asia FX slips as traders weigh Trump tariff threat, Iran unrest, Fed independence [ad_2] Source link

[ad_1] Dollar wobbles as markets fret about threat to Fed independence [ad_2] Source link

[ad_1] Japan finance minister says US Treasury’s Bessent shares concerns over weak yen [ad_2] Source link